Friday, July 10, 2026

Drug profile · INN

aceneuramic acid

aceneuramic acid (ACENOBEL) is an FDA-listed pharmaceutical active ingredient.

PMDA: approved
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — aceneuramic acid
Class
Route
Patents
0
Programs
3
Data quality
0.78

Quick answer

aceneuramic acid (ACENOBEL) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN aceneuramic acid
Brand ACENOBEL

Approval history

Authority Status Date
PMDA approved

Pipeline programs

  1. Aceneuramic Acid Extended-Release Tablets Phase 3 · Ultragenyx UK · Hereditary Inclusion Body Myopathy
  2. aceneuramic acid extended-release (Ace-ER) Phase 3 · Ultragenyx UK · Hereditary Inclusion Body Myopathy
  3. Aceneuramic Acid Extended-Release Phase 2 · Ultragenyx UK · Hereditary Inclusion Body Myopathy

Frequently asked questions

What is aceneuramic acid?

aceneuramic acid (ACENOBEL) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for aceneuramic acid?

ACENOBEL is a marketed brand name for aceneuramic acid. Check FDA Drugs@FDA for the current US label holder and prescribing information.